The remaining hTERT promoter mutated, 1p19q codeleted sample, Sample 13, had a TP53 mutation and was considered 1p19q codeleted at a threshold of 30% of tumor cells exhibiting 1p19q codeletion by a pathology report from an outside institution (Supplementary Table S2). Here, TP53 is linked to neoplasm.